On the public citation graph

Identifying Novel Candidates for Re-Purposing as Potential Therapeutic Agents for Alzheimer’s disease

0 signed · 23 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/14651858.cd001190.pub3openalex-snapshot
Donepezil for dementia due to Alzheimer's disease
inferredcites →https://doi.org/10.1007/s00125-017-4372-6openalex-snapshot
Repurposing metformin for the prevention of cancer and cancer recurrence
inferredcites →https://doi.org/10.1016/s0140-6736(17)31363-6openalex-snapshot
Dementia prevention, intervention, and care
inferredcites →https://doi.org/10.1038/npp.2012.253openalex-snapshot
Glucocorticoid-Related Molecular Signaling Pathways Regulating Hippocampal Neurogenesis
inferredcites →https://doi.org/10.1038/nrd3869openalex-snapshot
Drug repositioning for Alzheimer's disease
inferredcites →https://doi.org/10.1038/s41398-018-0231-6openalex-snapshot
A role for APP in Wnt signalling links synapse loss with β-amyloid production
inferredcites →https://doi.org/10.1056/nejmoa1106668openalex-snapshot
Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
inferredcites →https://doi.org/10.1056/nejmoa1705971openalex-snapshot
Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
inferredcites →https://doi.org/10.1056/nejmoa1812840openalex-snapshot
Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease
inferredcites →https://doi.org/10.1093/nar/gkl887openalex-snapshot
NCBI GEO: mining tens of millions of expression profiles--database and tools update
inferredcites →https://doi.org/10.1096/fj.08-113795openalex-snapshot
Minocycline reduces the development of abnormal tau species in models of Alzheimer's disease
inferredcites →https://doi.org/10.1097/jcp.0000000000001015openalex-snapshot
Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers With Psychotic, Anxiety, and Mood Disorders in the EAGLES Trial
inferredcites →https://doi.org/10.1111/ejn.12142openalex-snapshot
Amyloid β inhibits retinoic acid synthesis exacerbating A lzheimer disease pathology which can be attenuated by an retinoic acid receptor α agonist
inferredcites →https://doi.org/10.1177/1087057108323909openalex-snapshot
Identification of Small Molecule Inhibitors of β-Amyloid Cytotoxicity through a Cell-Based High-Throughput Screening Platform
inferredcites →https://doi.org/10.1186/1471-2164-14-765openalex-snapshot
SPIEDw: a searchable platform-independent expression database web tool
inferredcites →https://doi.org/10.1212/wnl.0b013e31824e8f0dopenalex-snapshot
Amantadine

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/prp2.841openalex-snapshot
Drug repurposing strategies of relevance for Parkinson’s disease
inferred← citeshttps://doi.org/10.1016/j.arr.2025.102693openalex-snapshot
Does drug repurposing bridge the gaps in management of Parkinson’s disease? Unravelling the facts and fallacies
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c00335openalex-snapshot
Mechanistic Insights for Drug Repurposing and the Design of Hybrid Drugs for Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1038/s41582-020-0397-4openalex-snapshot
Drug repositioning and repurposing for Alzheimer disease
inferred← citeshttps://doi.org/10.3389/fpsyt.2021.661233openalex-snapshot
Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?
inferred← citeshttps://doi.org/10.3390/ph19020301openalex-snapshot
Rethinking Nature’s Pharmacy: AI Era and Natural Product Drug Discovery
inferred← citeshttps://doi.org/10.7841/ksbbj.2025.40.4.327openalex-snapshot
Recent Advances and Strategies in Drug Repurposing for Alzheimer’s Disease Therapy
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.